Pages that link to "Q28326877"
Jump to navigation
Jump to search
The following pages link to Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment (Q28326877):
Displaying 45 items.
- The biology and control of phlebotomine sand flies (Q28138317) (← links)
- Epidemiology of the leishmaniases. (Q30416971) (← links)
- Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis (Q31404977) (← links)
- T-cell response in human leishmaniasis (Q33538305) (← links)
- Cutaneous Manifestations of Human and Murine Leishmaniasis (Q33839048) (← links)
- Leishmaniasis in the Sudan: a literature review with emphasis on clinical aspects (Q34037916) (← links)
- Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches (Q34141558) (← links)
- CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity (Q34529549) (← links)
- Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients (Q34695532) (← links)
- Post-kala-azar dermal leishmaniasis. (Q35057435) (← links)
- A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study (Q36141411) (← links)
- The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. (Q36370082) (← links)
- Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity (Q36399862) (← links)
- Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan. (Q38108301) (← links)
- Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis (Q39245966) (← links)
- Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis (Q39554070) (← links)
- Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study. (Q41461856) (← links)
- Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing (Q41503992) (← links)
- Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiop (Q41787486) (← links)
- Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population (Q41830302) (← links)
- Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis (Q42504757) (← links)
- Pathology of post-kala-azar dermal leishmaniasis: a light microscopical, immunohistochemical, and ultrastructural study of skin lesions and draining lymph nodes (Q42505742) (← links)
- Report of the Post Kala-azar Dermal Leishmaniasis (PKDL) Consortium Meeting, New Delhi, India, 27-29 June 2012. (Q42537676) (← links)
- Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis (Q42721940) (← links)
- Misdiagnosis and mistreatment of post-kala-azar dermal leishmaniasis. (Q43226918) (← links)
- Leishmaniasis in Sudan. Mucosal leishmaniasis (Q43615699) (← links)
- Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL). (Q44884159) (← links)
- Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile (Q46403854) (← links)
- High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis (Q46509813) (← links)
- Infection rates with Leishmania donovani and Mycobacterium tuberculosis in a village in eastern Sudan (Q46523934) (← links)
- Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis. (Q46760054) (← links)
- Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment (Q46882051) (← links)
- Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis. (Q48077921) (← links)
- Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. (Q51902268) (← links)
- The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC) (Q57633695) (← links)
- High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis (Q57633729) (← links)
- Post-kala-azar dermal leishmaniasis in Nepal (Q58850605) (← links)
- VISCERAL LEISHMANIASIS (Q58863010) (← links)
- Visceral Leishmaniasis - Current Treatments and Needs (Q59003562) (← links)
- Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis (Q60956585) (← links)
- Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy (Q64071713) (← links)
- Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody (Q73530373) (← links)
- Identification of parasite antigen, correlation of parasite density and inflammation in skin lesions of post kala-azar dermal leishmaniasis (Q75335226) (← links)
- Post kala-azar ocular leishmaniasis (Q77384710) (← links)
- Biomarkers in Post-kala-azar Dermal Leishmaniasis (Q92652683) (← links)